Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells
出版年份 2011 全文链接
标题
Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 301, Issue 6, Pages E1143-E1154
出版商
American Physiological Society
发表日期
2011-09-07
DOI
10.1152/ajpendo.00208.2011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lack of Association Between Adiponectin Levels and Atherosclerosis in Mice
- (2010) Andrea R. Nawrocki et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization
- (2010) John T. Heiker et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Macrophage Adiponectin Expression Improves Insulin Sensitivity and Protects Against Inflammation and Atherosclerosis
- (2010) N. Luo et al. DIABETES
- Dimerization of adiponectin receptor 1 is inhibited by adiponectin
- (2010) D. Kosel et al. JOURNAL OF CELL SCIENCE
- Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway
- (2010) Chun-Yin Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts
- (2010) Dong Fan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-κB, and STAT3 signaling pathways
- (2009) Josef Wanninger et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1
- (2009) Nobuhisa Nakamura et al. FEBS LETTERS
- Globular adiponectin inhibits angiotensin II-induced nuclear factor κB activation through AMP-activated protein kinase in cardiac hypertrophy
- (2009) Cheng Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Induction of gene expression in response to globular adiponectin in vascular endothelial cells
- (2009) Atsuko Tomizawa et al. LIFE SCIENCES
- Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism
- (2009) K. Ohashi et al. MOLECULAR AND CELLULAR BIOLOGY
- Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-κB pathways
- (2009) Chih-Hsin Tang et al. PROSTATE
- Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells
- (2008) Peng Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma Adiponectin Complexes Have Distinct Biochemical Characteristics
- (2008) Todd Schraw et al. ENDOCRINOLOGY
- Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature
- (2008) Carmela Nacci et al. ENDOCRINOLOGY
- Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes
- (2008) Yasumasa Ikeda et al. FEBS LETTERS
- High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-κB activation in vascular endothelial cells
- (2008) Yoshiyuki Hattori et al. FEBS LETTERS
- Regulation of globular adiponectin-induced apoptosis by reactive oxygen/nitrogen species in RAW264 macrophages
- (2008) S AKIFUSA et al. FREE RADICAL BIOLOGY AND MEDICINE
- Protective vascular and myocardial effects of adiponectin
- (2008) Barry J Goldstein et al. Nature clinical practice. Cardiovascular medicine
- Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia
- (2007) Helena Vaverkova et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started